Center for Medical Weight Loss (CMWL)
CMWL sells compounded GLP-1 treatment and wellness products. Its safety notice separates those preparations from approved drugs; confirm the assigned clinician, pharmacy and monitoring.
Review by Molly Ward, goal-guide writer · Updated October 2026
The short version
The medication disclosure is more useful than the headline savings. Before treatment, identify the actual prescriber and pharmacy, clarify monitoring, and resolve any product-page conflicts.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: Tirzepatide injection, from $239/mo
Visit Center for Medical Weight Loss (CMWL) →Center for Medical Weight Loss, or CMWL, offers a remote prescription pathway under BE-THIN INC. The current menu includes semaglutide, tirzepatide, sermorelin, NAD+ and glutathione. These are not interchangeable treatments. Its safety document describes compounded semaglutide and tirzepatide, rather than promising the approved branded formulations used in major trials.
What Center for Medical Weight Loss (CMWL) prescribes, by goal
Weight
- TirzepatideFDA-approved
- Injection (compounded)From $239/mo
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
GLP-1 pages identify flat dose pricing, but price stability does not determine the appropriate dose or treatment choice. The safety disclosure addresses contraindications, individualized need and pharmacy instructions. Confirm the exact formulation and administration directions rather than copying a dose from marketing or another patient.
Longevity
- NAD+Compounding conditions apply
- Injection (compounded)Price not published
- Nasal spray (compounded)Price not published
- GlutathioneCompounding conditions apply
Listed by the seller; no price we hold.
NAD+ is a coenzyme, and the wellness menu also includes sermorelin and glutathione. The pages acknowledge limits in the supporting research. Neither the presence of a clinician nor an ingredient’s biological role establishes an anti-aging benefit for an individual.
Recovery
- SermorelinCompounding conditions apply
Listed by the seller; no price we hold.
Sleep
- SermorelinCompounding conditions apply
Listed by the seller; no price we hold.
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
Kevin Jovanovic, MD, OB/GYN, is identified as chief medical officer. The medical-safety notice describes networks of U.S.-licensed clinicians who independently decide whether to prescribe. A leadership biography does not identify the practitioner assigned to a particular patient. Obtain that person’s name, credentials and licensed state before relying on continuing care.
A health questionnaire precedes a clinical review and any prescription. The safety notice says an assessment alone does not establish a doctor-patient relationship. Product pages describe follow-up messaging and check-ins, without establishing one universal appointment interval. A video or phone visit is not mentioned as a universal prerequisite. Ask whether a live consultation is needed and how urgent medication concerns reach the treating clinician.
Are labs required?
Not mentioned
No universal baseline panel, testing interval or included laboratory amount is established by the advertised GLP package. Ask what the clinician requires for your history and who reviews the results. Medication support and free delivery do not establish that outside testing is free.
Ready to start with Center for Medical Weight Loss (CMWL)?
Lowest listed price: Tirzepatide injection, from $239/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
The semaglutide and tirzepatide pages distinguish the published branded-drug trials from CMWL’s compounded preparations. That distinction matters: those trials do not directly test the product a partner pharmacy dispenses. Pharmacy-certification claims should also be checked against the actual dispensing business, which is not individually named in these product descriptions.
Other products and treatment claims
- Tesamorelin
- Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
- Compounded tesamorelin
- Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
- Unconfirmed product routes and nasal NAD price
- A menu label or biological explanation does not establish every administration route. The nasal NAD hero and FAQ also disagree on price.
How it bills
Calendar-month GLP plans are advertised at $149 for semaglutide and $239 for tirzepatide. Lower annual and quarterly equivalents require larger advance payments. The refund policy has specific conditions, including a same-day request and a $50 deduction in one post-review cancellation scenario. A nasal NAD page also presents conflicting amounts; confirm that product’s charge in writing.
For and against
- For: Separate compounded-product safety disclosure
- For: Named medical leadership
- For: GLP dose-price terms explicitly described
- For: Messaging and continuing clinical access offered
- Against: Assigned practitioner requires confirmation
- Against: Dispensing pharmacy not individually identified
- Against: Universal laboratory plan not established
- Against: Nasal NAD billing descriptions conflict
The evidence behind what it sells
- Semaglutide Side Effects: What the Wegovy Trials and Label Recorded
- Glutathione Side Effects: What Injection, IV and Oral Studies Reported
- Sermorelin Side Effects: What the Trials and FDA Record Report
- Tirzepatide Side Effects: What the Zepbound Label and Trials Recorded
- NAD Side Effects: What Injection, IV and Oral Precursor Studies Reported
- Does Sermorelin Work? What the Human Studies Measured
Right for
A patient willing to confirm product identity, monitoring and pharmacy details before choosing a remote prescription program.
Look elsewhere if
Someone treating branded-drug trial results as direct proof for every compounded preparation or wellness claim.
Other sellers for weight
Luvo Health
Also prescribes Tirzepatide, Semaglutide.
Care Bare Rx
Also prescribes Tirzepatide, Semaglutide.
PreventiveMD
Also prescribes Tirzepatide, Semaglutide.
Center for Medical Weight Loss (CMWL)
Frequently asked questions
- Does CMWL dispense the branded formulation used in the cited trials?
- The GLP program describes compounded preparations. Its safety document distinguishes those products from approved brands.
- Is the named medical director necessarily the treating clinician?
- No. Confirm the practitioner assigned to your evaluation and continuing prescription care.
- Does free delivery establish that testing is included?
- No. Obtain the clinician’s actual testing requirements and any separate laboratory charges.
Sources
- Monthly GLP plans and dose-price terms
- Tirzepatide treatment and prescription scope
- Program medication safety disclosure
- Order refund conditions
- Business identity and subscription agreement
- NAD injection product and billing options
- Nasal NAD pricing discrepancy
- Sermorelin care description
See what Center for Medical Weight Loss (CMWL) prescribes today
Center for Medical Weight Loss (CMWL) sets its own prices, plans and the states it serves. Check them before you start.